These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21710270)

  • 21. Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases.
    Donners R; Candito A; Blackledge M; Rata M; Messiou C; Koh DM; Tunariu N
    Br J Radiol; 2023 Nov; 96(1151):20230378. PubMed ID: 37660399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis.
    Wetter A; Lipponer C; Nensa F; Heusch P; Rübben H; Schlosser TW; Pöppel TD; Lauenstein TC; Nagarajah J
    Ann Nucl Med; 2014 Jun; 28(5):405-10. PubMed ID: 24595461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
    Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
    Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
    Kido A; Tamada T; Sone T; Kanomata N; Miyaji Y; Yamamoto A; Ito K
    Radiol Med; 2017 Mar; 122(3):228-238. PubMed ID: 27943099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?
    Metens T; Miranda D; Absil J; Matos C
    Eur Radiol; 2012 Mar; 22(3):703-9. PubMed ID: 21971824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Feasibility and clinical value of whole body diffusion weighted magnetic resonance imaging in detection of bone metastases].
    Li S; Xue HD; Sun F; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):192-9. PubMed ID: 19507599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.
    Wolf MB; Edler C; Tichy D; Röthke MC; Schlemmer HP; Herfarth K; Bonekamp D
    J Magn Reson Imaging; 2017 Sep; 46(3):850-860. PubMed ID: 28152251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot study on the detection of antiandrogen resistance using serial diffusion-weighted imaging of bone metastases in prostate cancer.
    Reischauer C; Koh DM; Froehlich JM; Patzwahl R; Binkert CA; Gutzeit A
    J Magn Reson Imaging; 2016 Jun; 43(6):1407-16. PubMed ID: 26587694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
    Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
    Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging of focal vertebral bone marrow lesions: initial experience of the differentiation of nodular hyperplastic hematopoietic bone marrow from malignant lesions.
    Park S; Kwack KS; Chung NS; Hwang J; Lee HY; Kim JH
    Skeletal Radiol; 2017 May; 46(5):675-683. PubMed ID: 28265697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
    Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
    Anticancer Res; 2017 Sep; 37(9):5027-5032. PubMed ID: 28870929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
    Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
    J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer.
    Park SY; Shin SJ; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ; Oh YT
    Eur Radiol; 2017 Jul; 27(7):2776-2783. PubMed ID: 27957637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Prostate Cancer Metastasis by Whole Body Magnetic Resonance Imaging Combined with Bone Scintigraphy and PSA Levels.
    An H; Tao N; Li J; Guan Y; Wang W; Wang Y; Wang F
    Cell Physiol Biochem; 2016; 40(5):1052-1062. PubMed ID: 27941343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective comparison of
    Zacho HD; Nielsen JB; Afshar-Oromieh A; Haberkorn U; deSouza N; De Paepe K; Dettmann K; Langkilde NC; Haarmark C; Fisker RV; Arp DT; Carl J; Jensen JB; Petersen LJ
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1884-1897. PubMed ID: 29876619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Texture analysis of apparent diffusion coefficient maps for treatment response assessment in prostate cancer bone metastases-A pilot study.
    Reischauer C; Patzwahl R; Koh DM; Froehlich JM; Gutzeit A
    Eur J Radiol; 2018 Apr; 101():184-190. PubMed ID: 29571795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.
    deSouza NM; Riches SF; Vanas NJ; Morgan VA; Ashley SA; Fisher C; Payne GS; Parker C
    Clin Radiol; 2008 Jul; 63(7):774-82. PubMed ID: 18555035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.